Epidemiology of gut and liver multimorbidities in the context of chronic intestinal schistosomiasis
Epidemiology of gut and liver multimorbidities in the context of chronic intestinal schistosomiasis
批准号:
EP/X021793/1
负责人:
Goylette Chami
金额:
$249.73万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Intestinal schistosomiasis is characterised by progressive injury to the gut and liver and caused by an infection of long duration with parasitic blood flukes (Schistosoma mansoni). Most infected individuals live in sub-Saharan Africa. Associated conditions include gut inflammation, hepatosplenomegaly, periportal fibrosis, portal hypertension, upper gastrointestinal bleeding, ascites, anaemia, and undernutrition. Mass drug administration (MDA) of praziquantel is used to treat the blood flukes instead of the conditions, relying on reaching individuals before morbidity develops.As a group of chronic conditions with complex aetiologies, we propose studying intestinal schistosomiasis as a set of multimorbidities as opposed to the conventional view as a single disease. Multimorbidity is the coexistence of 2+ chronic conditions within an individual irrespective of cause. It is rising worldwide and complicating diagnosis and case management. In Uganda, we recently discovered a high burden of gut and liver conditions despite repeated MDA. To establish the epidemiology of multimorbidities, we propose the following hypothesis. In the context of MDA, the accumulation and clustering of chronic S. mansoni-associated conditions within an individual, even in the short term (few years), is largely explained by interactions of those coexisting conditions and shared social-ecological risk factors between conditions within individuals. In Eastern and Western Uganda, we will establish a longitudinal, community-based cohort of 3,280 individuals for four years with six study periods. With major fieldwork, clinical and social epidemiology, and cutting-edge machine learning, our objectives are to 1) identify common clusters and interactions of gut and liver conditions; 2) develop computational tools to predict social-ecological patterning and condition trajectories; and 3) assess multimorbidities using patient-reported symptoms and priorities, and local health worker knowledge.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pntd.0011377
发表时间:
2023-06
期刊:
PLOS NEGLECTED TROPICAL DISEASES
影响因子:
3.8
作者:
[Reitzug, Fabian, Ledien, Julia, Chami, Goylette F.]
通讯作者:
Chami, Goylette F.
The epidemiology of periportal fibrosis and relevance of current Schistosoma mansoni infection: a population-based, cross-sectional study
门静脉周围纤维化的流行病学和当前曼氏血吸虫感染的相关性:基于人群的横断面研究
DOI:
10.1101/2023.09.15.23295612
发表时间:
2023
期刊:
影响因子:
--
作者:
[Anjorin S]
通讯作者:
Anjorin S
国内基金
海外基金
登录
查看更多内容
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
-
批准号:82372306
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:彭奕冰
-
依托单位:
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
-
批准号:82371251
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:肖勤
-
依托单位:
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
-
批准号:81801389
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:田茗源
-
依托单位:
酰基化脑肠肽抑制脑缺血引起神经元凋亡的分子机制
-
批准号:30370557
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2003
-
负责人:祝世功
-
依托单位: